A detailed history of Excalibur Management Corp transactions in Medtronic PLC stock. As of the latest transaction made, Excalibur Management Corp holds 3,673 shares of MDT stock, worth $284,180. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,673
Previous 3,682 0.24%
Holding current value
$284,180
Previous $303,000 5.61%
% of portfolio
0.14%
Previous 0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$82.84 - $88.09 $745 - $792
-9 Reduced 0.24%
3,673 $320,000
Q4 2023

Feb 12, 2024

BUY
$69.43 - $83.43 $37,839 - $45,469
545 Added 17.37%
3,682 $303,000
Q3 2023

Nov 09, 2023

BUY
$78.22 - $90.4 $5,006 - $5,785
64 Added 2.08%
3,137 $245,000
Q2 2023

Aug 08, 2023

BUY
$79.47 - $91.38 $1,192 - $1,370
15 Added 0.49%
3,073 $270,000
Q4 2022

Feb 10, 2023

BUY
$76.18 - $87.74 $32,376 - $37,289
425 Added 16.14%
3,058 $237,000
Q3 2022

Nov 04, 2022

BUY
$80.75 - $95.31 $5,571 - $6,576
69 Added 2.69%
2,633 $213,000
Q2 2022

Jul 25, 2022

BUY
$87.4 - $113.09 $3,496 - $4,523
40 Added 1.58%
2,564 $230,000
Q1 2022

May 03, 2022

BUY
$100.58 - $112.38 $1,106 - $1,236
11 Added 0.44%
2,524 $280,000
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $2,687 - $3,449
27 Added 1.09%
2,513 $260,000
Q3 2021

Oct 28, 2021

BUY
$122.75 - $135.17 $7,610 - $8,380
62 Added 2.56%
2,486 $312,000
Q2 2021

Jul 26, 2021

SELL
$118.19 - $131.5 $6,500 - $7,232
-55 Reduced 2.22%
2,424 $301,000
Q3 2020

Nov 02, 2020

SELL
$90.13 - $108.78 $12,167 - $14,685
-135 Reduced 5.16%
2,479 $258,000
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $504 - $619
-6 Reduced 0.23%
2,614 $240,000
Q1 2020

May 15, 2020

BUY
$72.92 - $121.3 $6,854 - $11,402
94 Added 3.72%
2,620 $236,000
Q4 2019

Feb 04, 2020

BUY
$104.49 - $114.54 $263,941 - $289,328
2,526 New
2,526 $287,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Excalibur Management Corp Portfolio

Follow Excalibur Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.